Dr Michael O’Neill, Inflection Biosciences' Director of R&D interviewed by Pharma Television
Dublin, Ireland, 16 August 2013 Inflection Biosciences Ltd, a private company focused on the development of targeted small molecule...
Dr Michael O’Neill, Inflection Biosciences' Director of R&D interviewed by Pharma Television
Inflection Licenses Preclinical Oncology Programs from the Spanish National Cancer Research Centre
Inflection Biosciences Selected to Present at International Investor Forum
Inflection Biosciences to attend 24th Annual EORTC-NCI-AACR Symposium